1. Dai, Yan, Shaikho, Elmutaz M, Perez, Jessica, Sebastiani, Paola, Steinberg, Martin H. . BCL2L1 is associated with γ-globin gene expression. In Blood advances, 3, 2995-3001. doi:10.1182/bloodadvances.2019032243. https://pubmed.ncbi.nlm.nih.gov/31648320/
2. Khan, Sajid, Zhang, Xuan, Lv, Dongwen, Zheng, Guangrong, Zhou, Daohong. 2019. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. In Nature medicine, 25, 1938-1947. doi:10.1038/s41591-019-0668-z. https://pubmed.ncbi.nlm.nih.gov/31792461/
3. Barbie, David A, Tamayo, Pablo, Boehm, Jesse S, Jacks, Tyler, Hahn, William C. 2009. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. In Nature, 462, 108-12. doi:10.1038/nature08460. https://pubmed.ncbi.nlm.nih.gov/19847166/
4. Hanna, Ruth E, Hegde, Mudra, Fagre, Christian R, Neal, James T, Doench, John G. . Massively parallel assessment of human variants with base editor screens. In Cell, 184, 1064-1080.e20. doi:10.1016/j.cell.2021.01.012. https://pubmed.ncbi.nlm.nih.gov/33606977/
5. Beroukhim, Rameen, Mermel, Craig H, Porter, Dale, Sellers, William R, Meyerson, Matthew. . The landscape of somatic copy-number alteration across human cancers. In Nature, 463, 899-905. doi:10.1038/nature08822. https://pubmed.ncbi.nlm.nih.gov/20164920/
6. Yin, Ling, Hu, Xiaoding, Pei, Guangsheng, Feng, Xu, Chen, Junjie. 2024. Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. In Life science alliance, 7, . doi:10.26508/lsa.202302353. https://pubmed.ncbi.nlm.nih.gov/38316463/
7. Wang, Jian-Xun, Gao, Jie, Ding, Su-Ling, Zhou, Zhixia, Li, Pei-Feng. 2015. Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w. In Molecular cell, 59, 50-61. doi:10.1016/j.molcel.2015.05.003. https://pubmed.ncbi.nlm.nih.gov/26028536/
8. Izumi, Motohiro, Fujii, Masanori, Kobayashi, Ikei S, Costa, Daniel B, Kobayashi, Susumu S. 2024. Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer. In Cell death & disease, 15, 580. doi:10.1038/s41419-024-06940-y. https://pubmed.ncbi.nlm.nih.gov/39122703/